Publikationen von Felix G. Rebitschek

Rebitschek, F. G., Gigerenzer, G., Keitel, A., Sommer, S., Groß, C., & Wagner, G. G. (2021). Acceptance of criteria for health and driver scoring in the general public in Germany. PLoS ONE, 16(4), Article e0250224. https://doi.org/10.1371/journal.pone.0250224

Rebitschek, F. G., Gigerenzer, G., & Wagner, G. G. (2021). People underestimate the errors made by algorithms for credit scoring and recidivism prediction but accept even fewer errors. Scientific Reports, 11, Article 20171. https://doi.org/10.1038/s41598-021-99802-y

Rebitschek, F. G., & Gigerenzer, G. (2020). Einschätzung der Qualität digitaler Gesundheitsangebote: Wie können informierte Entscheidungen gefördert werden? Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 63, 665–673. https://doi.org/10.1007/s00103-020-03146-3

Rebitschek, F. G., & Wagner, G. G. (2020). Akzeptanz von assistiven Robotern im Pflege- und Gesundheitsbereich: Repräsentative Daten zeichnen ein klares Bild für Deutschland. Zeitschrift für Gerontologie und Geriatrie, 53, 637–643. https://doi.org/10.1007/s00391-020-01780-9

McDowell, M. E., Gigerenzer, G., Wegwarth, O., & Rebitschek, F. G. (2019). Effect of tabular and icon fact box formats on comprehension of benefits and harms of prostate cancer screening: A randomized trial. Medical Decision Making, 39(1), 41–56. https://doi.org/10.1177/0272989X18818166

Rebitschek, F. G., Pashayan, N., Widschwendter, M., & Wegwarth, O. (2019). Do cancer risk and benefit-harm ratios influence women's consideration of risk-reducing mastectomy? A scenario-based experiment in five European countries. PLoS ONE, 14(6), Article e0218188. https://doi.org/10.1371/journal.pone.0218188

Rebitschek, F. G., Reisel, D., Lein, I., & Wegwarth, O. (2019). Epigenetic risk assessment of female cancers: Women's information needs and attitudes. Public Health Genomics, 22(1-2), 46–57. https://doi.org/10.1159/000501975

Speiser, D., Rebitschek, F. G., Feufel, M. A., Brand, H., Besch, L., & Kendel, F. (2019). Accuracy in risk understanding among BRCA1/2-mutation carriers. Patient Education and Counseling, 102(10), 1925–1931. https://doi.org/10.1016/j.pec.2019.05.007

Wegwarth, O., Pashayan, N., Widschwendter, M., & Rebitschek, F. G. (2019). Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: A cross-sectional online survey. BMC Public Health, 19, Article 667. https://doi.org/10.1186/s12889-019-6994-8

Gigerenzer, G., Rebitschek, F. G., & Wagner, G. G. (2018). Eine vermessene Gesellschaft braucht Transparenz. Wirtschaftsdienst, 98(12), 860–866. https://doi.org/10.1007/s10273-018-2378-4